ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Seffalair Spiromax 232/14 mcg, Multidosenpulverinhalator - 60
67891003 Teva Pharma AG
Seffalair Spiromax 232/14 mcg, Multidosenpulverinhalator12.04.2021
  12.04.2021
Salmeterol and Fluticasone (R03AK06) 
WHO-DDD11.04.2026
03.04.30.60
03.04.30. 
B  
Yes 
IP 
55.49No
    
10 %76.75
  
7680678910035Synthetika
  
Composition
fluticasoni propionas 202 µg, salmeterolum 12.75 µg ut salmeteroli xinafoas, lactosum monohydricum ad pulverem pro dosi, doses pro vase 60.
Packungsbestandteile
  
  
 
Active AgentDose
 202 µg
Salmeterol12.75 µg
BAG: Active AgentDose
Fluticasoni-17 Propionas202 mcg
Salmeterol12.75 mcg
 
Inactive agents
Lactose Monohydrate
 
Source
Data was imported : 12.05.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home